期刊文献+

富含半胱氨酸61在人皮肤恶性肿瘤中的表达 被引量:3

下载PDF
导出
摘要 富含半胱氨酸61(Cyr61,又称为CCNI)是结缔组织生长因子(CCN)家族关键成员之一.是一种非常重要的细胞基质调节因子.调控内皮细胞和成纤维细胞的黏附、迁移与增殖,诱导血管发生,参与炎症反应、伤口愈合和组织重塑等过程。近年来.Cyr61与肿瘤的关系越来越受关注。
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2013年第8期468-470,共3页 Journal of Clinical Dermatology
基金 上海高校青年教师培养资助计划(编号:2011-shjdy33) 上海交通大学医学院附属第九人民医院院基金(编号:JY2011A16)资助项目
  • 相关文献

参考文献14

  • 1Perbal B. CCN proteins: multifunctional signalling regulators[J]. Lancet, 2004, 363(9402): 62-64.
  • 2Brigstock DR. The connective tissue growth factor/ cysteine- rich61/ nephroblastoma overexpressed (CCN) family[J]. Endoc Rev,1999, 20(2): 189-206.
  • 3Mo FE, Muntean AG, Chen CC, et al. CYR61 (CCN1) is essen- tial for placental development and vascular integrity[J]. Mol Cell Biol, 2002, 22(24): 8709-8720.
  • 4Holloway SE, Beck AW, Girard L, et al. Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer[J]. J Am Coil Surg, 2005, 200(3): 371-377.
  • 5Haque I, Mehta S, Majumder M, et al. Cyr61/CCNI signaling is critical for epithelial-mesenchymal transition and sternness and promotes pancreatic carcinogenesis [J]. Molecular Cancer, 2011, 13(10): 8.
  • 6李志强,司维柯,丁伟,李军,潘静.Cyr61在人肿瘤组织中的表达[J].第三军医大学学报,2010,32(5):478-481. 被引量:3
  • 7Babic AM, Kireeva ML, Kolesnikova TV, et al. CYR61, a prod- uct of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth[J]. Proc Natl Acad Sci, 1998, 95(11): 6355-6360.
  • 8Kunz M, Moeller S, Koczan D, et al. Mechanisms of hypoxic gene regulation of angiogenesis factor Cyr61 in melanoma cells [J]. J Biol Chem, 2003, 278(46): 45651-45660.
  • 9Dobroff AS, Wang H, Melnikova VO, et al. Silencing cAMP-re- sponse element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma[J]. J Biol Chem, 2009, 284 (38): 26194-26206.
  • 10Mitchell TW, Nissanov J, Han LY, et al. novel method to quantify neuropil threads in brains from eiders with or without eognitive impairment[J]. J Histoehem Cytochem, 2000, 48(12): 1627-1638.

二级参考文献37

  • 1Kireeva M L, Mo F E, Yang G P, et al. Cyt61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion[J]. Mol Cell Biol, 1996, 16(4): 1326 - 1334.
  • 2Wasenius V M, Hemmer S, Kettunen E, et al. Hepatoeyte growth fac-tor receptor, matrix metalloproteinase-11, tissue inhibitor of metallopro- teinase-1, and fibronectin are up-regulated in papillary, thyroid carcino- ma: a cDNA and tissue microarray study[J]. Clin Cancer Res, 2003, 9(1): 68-75.
  • 3Xie D, Yin D, Tong X, et al. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/ Lef signaling pathways[J]. Cancer Res, 2004, 64(6) : 1987 - 1996.
  • 4Xie D, Yin D, Wang H J, et al. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas[J]. Clin Cancer Res, 2004, 10(6) : 2072 -2081.
  • 5Huang X, Xiao D W, Xu L Y, et al. Prognostic significance of altered expression of SDC2 and CYR61 in esophageal squamous cell carcinoma [J]. OncolRep, 2009, 21(4): 1123 -1129.
  • 6Lin M T, Zuon C Y, Chang C C, et al. Cyr61 induces gastric cancer cell motility/invasion via activation of the integrln/nuclear factor-kap- paB/cyclooxygenase-2 signaling pathway[ J]. Clin Cancer Res, 2005, 11(16) : 5809 -5820.
  • 7Jiang W G, Watkins G, Fodstad O, et al. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer [J]. Endocr Relat Cancer, 2004, 11(4) : 781 -791.
  • 8Nguyen N, Kuliopulos A, Graham R A, et al. Tumor-derived Cyr61 (CCNI) promotes stromal matrix metalloproteinase-1 production and protease-activaled receptor l-dependent migration of breast cancer cells[ J ]. Cancer Res, 2006, 66 (5) : 2658 - 2665.
  • 9Lin M T, Chang C C, Chen S T, et al. Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent X1AP up-regulation[ J ]. J Biot Chem, 2004, 279 ( 23 ) : 24015 - 24023.
  • 10Lv H, Fan E, Sun S, et al. Cyr61 is up-regulated in prostate cancer and associated with the p53 gene status[ J]. J Cell Biochem, 2009, 106(4) : 738 -744.

共引文献3

同被引文献15

  • 1吴品茹,刘健航.角质形成细胞在色素增加性疾病中的作用研究进展[J].中国美容医学,2007,16(5):703-705. 被引量:4
  • 2Imokawa G. Autoc, rine and paracrine regulation of melanocytes in human skin and in pigmentary disorders [J]. Pigment Cell Re- search, 2004, 17(2): 96-110.
  • 3Wu CS, Yu CL, Wu CS, et al. Narrow-band uhraviolet-B stim- ulates proliferation and migration of cultured melanocytes[J]. Ex- perimental Dermatology, 2004, 13(12): 755-763.
  • 4Hachiya A, Kobayashi A, Yoshida Y, et al. Biphasic expression of two paracrine melanogenic cytokines,stem cell factor and en- dothelin-l, in ultraviolet B-induced human melanogenesis [J]. American Journal of Pathology, 2004, 165(6): 99-109.
  • 5l~y RD. Animal models of ultraviolet radiation (UVR)-induced cutaneous melanoma[J]. Front Biosci, 2002, 7: d1531-d1534.
  • 6yon Thaler AK, Kamenisch Y, Berneburg M. The role of ultraviolet radiation in melanomagenesis[J]. Exp Dermatol, 2010, 9(2): 81-88.
  • 7Sim~es MC, Sousa JJ, Pais AA. Skin cancer and new treatment pe~pectives: a review[J]. Cancer Lett, 2015, 357(I): 8-42.
  • 8Maehara Y, Kabashima A, Koga T, et al. Vascular invasion and potential for tumor angiogenesis and metastasis in gastric cart.i- noma[J]. Surgery, 2000, 128(3): 408--416.
  • 9黄远深,李航,涂平,陈喜雪,杨淑霞,武玲慎,赵俊郁,李雪迎.632例皮肤恶性肿瘤及癌前病变临床分析[J].中华皮肤科杂志,2010,43(7):452-454. 被引量:34
  • 10徐航,江银华.着色性干皮病继发多种皮肤恶性肿瘤患者的护理及心理干预[J].中国实用护理杂志,2013,29(2):39-40. 被引量:1

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部